5 results
PW01-66 - Does Atomoxetine Improve Executive Function And Inhibitory Control As Measured By An Objective Computer-Based Test? A Randomized, Placebo-Controlled Study
-
- Journal:
- European Psychiatry / Volume 25 / Issue S1 / 2010
- Published online by Cambridge University Press:
- 17 April 2020, 25-E1465
-
- Article
-
- You have access
- Export citation
Metabolic syndrome in schizophrenia patients observed in German clinical practice - how do untreated patients differ from patients with previous antipsychotic medication?
-
- Journal:
- European Psychiatry / Volume 26 / Issue S2 / March 2011
- Published online by Cambridge University Press:
- 16 April 2020, p. 1425
-
- Article
-
- You have access
- Export citation
Preventing bipolar relapse: In which way do patients with mixed episodes differ?
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, pp. S262-S263
-
- Article
-
- You have access
- Export citation
Metabolic Syndrome in German Patients with Schizophrenia - Baseline-data from Treatment-naive Patients and Patients Previously Treated with Antipsychotics
-
- Journal:
- European Psychiatry / Volume 24 / Issue S1 / January 2009
- Published online by Cambridge University Press:
- 16 April 2020, 24-E1170
-
- Article
-
- You have access
- Export citation
Preventing bipolar relapse: Which factors are associated with different mood stabilizer therapy?
-
- Journal:
- European Psychiatry / Volume 22 / Issue S1 / March 2007
- Published online by Cambridge University Press:
- 16 April 2020, p. S262
-
- Article
-
- You have access
- Export citation